G. Di Maria (Catania, Italy), J. Roca (Barcelona, Spain)
Development of a powder for inhalation with R,R-Glycopyrrolate as active ingredient for the delivery from a novel multidose dry powder inhaler
S. Mueller, B. Fyrnys, M. Eilbracht, J. Goede (Frankfurt, Germany)
|  |
A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser
J. R. Smart, F. C. Lintz (Melbourn Science Park, United Kingdom; Munich, Germany)
| |
Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle
M. Keller, M. Borgschulte, R. Stangl, M. Knoch (Munich, Germany)
| |
Determination of tissue concentrations of metabolites in surgical preparations following inhalation of beclomethasone-dipropionate using conventional and extrafine aerosols
O. Holz, M. Einhaus, I. Zühlke, D. Branscheid, M. Nakashima, L. Welker, F. Kanniess, K. Richter, S. Hader, L. Harrison, R. A. Jörres, H. Magnussen (Grosshansdorf, Neuss, Germany; St Paul, United States Of America)
| |
Highly efficient peripheral lung targeting with coarse aerosols using brief very low inspiratory flow
A. R. Clark, C. B. Chambers, S. Paboojian, C. Schuler, D. Muir, M. T. Newhouse (San Carlos, United States Of America; Hamilton, Canada)
| |
Ex-vivo emitted dose characteristics for combination formulations in dry powder inhalers (DPI)
W. Y. Tarsin, K. S. Assi, S. B. Pearson, H. Chrystyn (Bradford, Leeds, United Kingdom)
| |
Reliability of aerosol output from a devilbiss 45 nebuliser
B. R. Thompson, F. Hartley, S. Khov, B. Borg (Prahran, Australia)
| |
In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates
D. Singh, P. Gilchrist, C. Niederlaender, B. Haeberlin (Basel, Switzerland)
| |
In-use in vitro performance of formoterol fumarate dihydrate powder for inhalation (6 and 12 µg/dose) delivered from a novel multidose dry powder inhaler
S. Mueller, B. Fyrnys (Frankfurt, Germany)
| |
Formoterol: a new pMDI CFC free formulation. cumulative dose safety versus a dry powder
V. Leclerc, M. Molimard, S. Rouanet, E. Vicaut, G. Lefrancois, P. A. Monici Preti (Courbevoie, Parma, France)
| |
Delivery of an HFA-formulated bronchodilator to the mechanically ventilated adult patient via holding chamber: laboratory simulation
J. P. Mitchell, M. W. Nagel, K. J. Wiersema, C. C. Doyle, V. A. Migounov (London, Canada)
| |
Does the inhalation device affect the bronchodilatory dose response curve of Salbutamol in asthma- and COPD patients?
M. Broeders, J. Molema, N. Vermue, H. Folgering (Groesbeek, Zeist, The Netherlands)
| |
Acceptability and efficacy of beclomethasone dipropionate (Béclojet HFA®) and fluticasone dipropionate (Flixotide HFA®, FDP) associated with the Volumatic® spacer in adults with mild to moderate persistent asthma
G. Huchon, M. Mueser, G. Lefrançois (Paris, Courbevoie, France)
| |
Assessment of handling of inhaler devices in real life in 3811 patients
M. Molimard, C. Raherison, S. Lignot, F. Depont, A. Abouelfath, N. Moore (Bordeaux, Pessac, France)
| |
Efficacy and patient/parent preference of asthma medication delivery systems in children and adolescents
T. Ninan, J. Ayres, D. Bellamy (Birmingham, Aberdeen, Bournemouth, United Kingdom)
| |
Differences in patient perceived side effects (PPSE) of inhaled corticosteroids (ICS) between metered dose inhalers (MDI) and dry powder inhalers (DPI)
G. Schraa, R. van der Werf, J. M. Foster, T. van der Molen (Aberdeen, United Kingdom; Groningen, The Netherlands)
| |
Can asthma be adequately treated with only one inhaler?
L. Larsson (Ostersund, Sweden)
| |
Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease
E. A. G. Demoncheaux, J. W. Fenner, B. Brook, R. Hose, D. Bee, K. McCormack, T. W. Higenbottam (Sheffield, Loughborough, United Kingdom)
| |
Gamma-scintigraphic evaluation of the delivered dose, lung deposition rate and distribution pattern of 99mTc-labelled tiotropium via dry powder inhaler
T. Meyer, T. Weuthen, E. Berkel, W. Timmer, C. Herpich, N. Weber (Gauting, Biberach, Germany)
| |
The trojan horse: a new gene therapeutic concept in pulmonology - endothelial progenitor cells as vector
C. M. Kähler, J. Wechselberger, J. Hamacher, W. Hilbe, G. Stockhammer, C. J. Wiedermann, E. Gunsilius (Innsbruck, Austria; Konstanz, Germany)
| |